Zembala Marian, Wilczek Krzysztof, Przybylski Roman, Chodór Piotr, Nadziakiewicz Paweł, Krasoń Marcin, Sadowski Jerzy, Dudek Dariusz, Kapelak Bogusław, Forysz Danuta, Witkowski Adam, Demkow Marcin, Chmielak Zbigniew, Kuśmierski Krzysztof, Juraszyński Zbigniew, Bochenek Andrzej, Cisowski Marek, Trusz-Gluza Maria, Buszman Paweł, Woś Stanisław, Kalarus Zbigniew, Poloński Lech, Gasior Mariusz, Opolski Grzegorz, Ruzyłło Witold
Slaskie Centrum Chorób Serca, Slaski Uniwersytet Medyczny, Zabrze.
Kardiol Pol. 2009 Aug;67(8):936-40.
Patients with severe symptomatic aortic stenosis, who from November 2008 to March 2009 were treated with Edwards-Sapien transcatheter aortic valve implantation (TAVI) within the POL-TAVI First Polish Registry, were included in the analysis. Nineteen patients aged 78+/-4.8 years with high operation risk and Logistic EuroSCORE 25+/-7.6% were reported (74% were females). In 15 (79%) patients the valve was implanted transapically (TA), in the other four (21%)--via the femoral arterial access (TF). The valve was successfully implanted in 16 (84%) patients, in one patient aortic valvuloplasty alone was performed. During in-hospital period two patients died (one during periprocedural period and another one--two months after the implantation). During the mean follow-up of 5+/-1.5 months (except for one patient who is still in hospital) all patients are in NYHA class I or II. Results of the initial series of 19 TAVI patients in Poland are satisfactory, and the trial will be continued with careful medical and economical analysis.
2008年11月至2009年3月期间，在波兰首个经导管主动脉瓣植入术（POL-TAVI）注册研究中接受爱德华兹-赛沛经导管主动脉瓣植入术（TAVI）治疗的重度症状性主动脉瓣狭窄患者被纳入分析。报告了19例年龄为78±4.8岁、手术风险高且欧洲心脏手术风险评估系统（Logistic EuroSCORE）评分为25±7.6%的患者（74%为女性）。15例（79%）患者经心尖植入瓣膜（TA），另外4例（21%）通过股动脉入路（TF）植入。16例（84%）患者瓣膜成功植入，1例患者仅进行了主动脉瓣成形术。住院期间2例患者死亡（1例在围手术期，另1例在植入后两个月）。在平均5±1.5个月的随访期间（除1例仍住院的患者外），所有患者的心功能均为纽约心脏协会（NYHA）I级或II级。波兰首批19例TAVI患者的初步结果令人满意，该试验将继续进行仔细的医学和经济学分析。
